# Focus on gut microbiota regulation: exploring the potential of fermented traditional Chinese medicines in the prevention and treatment of type 2 diabetes mellitus

**Authors:** Ruodi Yang, Yufeng Yang, Ying Zhou, Yuhang Shen, Yan Shi, Juntong Liu

PMC · DOI: 10.3389/fmicb.2026.1763653 · Frontiers in Microbiology · 2026-02-11

## TL;DR

This paper explores how fermented traditional Chinese medicines may help prevent and treat type 2 diabetes by regulating gut microbiota.

## Contribution

The study introduces fermented TCM as a novel approach for T2DM management through gut microbiota modulation.

## Key findings

- Fermented TCM modulates gut microbiota composition by increasing beneficial bacteria and decreasing harmful ones.
- Fermented TCM promotes short-chain fatty acid production, which aids glucose and energy metabolism.
- Fermented TCM protects intestinal barrier function and modulates intestinal immune responses.

## Abstract

Type 2 diabetes mellitus (T2DM), a globally prevalent metabolic disorder, has dysbiosis of the gut microbiota as a significant pathogenic factor. Traditional Chinese medicine (TCM) fermentation, originating from traditional processing techniques, is a technology that combines modern microbiological methods with solid-state fermentation, submerged fermentation, and bidirectional fermentation of medicinal fungi. Under specific conditions, it facilitates the biotransformation of herbal raw materials, demonstrating distinct advantages in regulating gut microbiota. This study aims to outline the concept of fermented TCM, elucidate the relationship between gut microbiota and T2DM, and explore the mechanisms by which fermented TCM modulates gut microbiota to improve T2DM. Literature searches in databases such as PubMed, Google Scholar, and Web of Science reveal that fermented TCM improves T2DM by targeting gut microbiota regulation as a core mechanism. The mechanisms may involve: modulating gut microbiota composition (fermentation products increase beneficial bacteria abundance, decrease harmful bacteria proportion, and restore microbial balance); influencing gut microbiota metabolites (promoting short-chain fatty acid (SCFA) production by microbiota, which participates in glucose and energy metabolism); protecting intestinal barrier function (SCFAs enhance intestinal epithelial cell function, upregulate tight junction protein expression, preserve barrier integrity, and reduce endotoxin leakage into the bloodstream); and modulating intestinal immune function (inhibiting inflammatory responses, enhancing antioxidant activity, and regulating intestinal immune homeostasis). This study reviews the application research of fermented TCM in improving T2DM by regulating the gut microbiota, aiming to validate and reveal its potential in the prevention and treatment of T2DM through gut microbiota modulation.

## Linked entities

- **Diseases:** type 2 diabetes mellitus (MONDO:0005148)

## Full-text entities

- **Genes:** PPARGC1A (PPARG coactivator 1 alpha) [NCBI Gene 10891] {aka LEM6, PGC-1(alpha), PGC-1alpha, PGC-1v, PGC1, PGC1A}, TJP1 (tight junction protein 1) [NCBI Gene 7082] {aka ZO-1}, SPDEF (SAM pointed domain containing ETS transcription factor) [NCBI Gene 25803] {aka PDEF, bA375E1.3}, OCLN (occludin) [NCBI Gene 100506658] {aka BLCPMG, PPP1R115, PTORCH1}, IL10 (interleukin 10) [NCBI Gene 3586] {aka CSIF, GVHDS, IL-10, IL10A, TGIF}, PPARA (peroxisome proliferator activated receptor alpha) [NCBI Gene 5465] {aka NR1C1, PPAR, PPAR-alpha, PPARalpha, hPPAR}, RYR2 (ryanodine receptor 2) [NCBI Gene 6262] {aka ARVC2, ARVD2, RYR-2, RyR, VACRDS, VTSIP}, TLR4 (toll like receptor 4) [NCBI Gene 7099] {aka ARMD10, CD284, TLR-4, TOLL}, PYY (peptide YY) [NCBI Gene 5697] {aka PYY-I, PYY1}, UCP2 (uncoupling protein 2) [NCBI Gene 7351] {aka BMIQ4, SLC25A8, UCPH}, MUC2 (mucin 2, oligomeric mucus/gel-forming) [NCBI Gene 4583] {aka MLP, MUC-2, SMUC}, GLP1R (glucagon like peptide 1 receptor) [NCBI Gene 2740] {aka GLP-1, GLP-1-R, GLP-1R}, SI (sucrase-isomaltase) [NCBI Gene 6476], INS (insulin) [NCBI Gene 3630] {aka IDDM, IDDM1, IDDM2, ILPR, IRDN, MODY10}
- **Diseases:** constipation (MESH:D003248), diarrhea (MESH:D003967), polyphagia (MESH:D006963), fatigue (MESH:D005221), obese (MESH:D009765), nausea (MESH:D009325), spleen-deficiency syndrome (MESH:D013160), T2DM (MESH:D003924), ulcerative colitis (MESH:D003093), hypoglycemic (MESH:C000721848), metabolic disease (MESH:D008659), bloating (MESH:C535647), DN (MESH:D003928), dyslipidemia (MESH:D050171), disorders of glucose and lipid metabolism (MESH:D052439), qi deficiency (MESH:D007153), hyperglycemic (MESH:D006944), qi-blood deficiency syndrome (MESH:D006402), hyperglycemia (MESH:D006943), metabolic syndrome (MESH:D024821), inflammation (MESH:D007249), insulin resistance (MESH:D007333), prediabetes (MESH:D011236), toxicity (MESH:D064420), numbness (MESH:D006987), polydipsia (MESH:D059606), polyuria (MESH:D011141), DM (MESH:D003920), gastrointestinal (MESH:D005767), dysbiosis (MESH:D064806), impaired fasting glucose (MESH:D007003), emaciation (MESH:D004614), Cold Damage (MESH:D000067390)
- **Chemicals:** streptozotocin (MESH:D013311), Propionic acid (MESH:C029658), lactulose (MESH:D007792), lipid (MESH:D008055), lactones (MESH:D007783), LPS (MESH:D008070), Butyric acid (MESH:D020148), Metformin (MESH:D008687), carbon dioxide (MESH:D002245), water (MESH:D014867), polyphenols (MESH:D059808), saponins (MESH:D012503), glycosides (MESH:D006027), blood glucose (MESH:D001786), SCFA (MESH:D005232), flavonoids (MESH:D005419), anthraquinones (MESH:D000880), glucose (MESH:D005947), ethanol (MESH:D000431), inulin (MESH:D007444), Acetic acid (MESH:D019342), acetate (MESH:D000085), sulfate (MESH:D013431), oligofructose (MESH:C120489), salts (MESH:D012492), all-trans retinoic acid (MESH:D014212), bile acid (MESH:D001647), Chinese herbal formulas (-), Acarbose (MESH:D020909), carbohydrates (MESH:D002241), carbon (MESH:D002244), phenols (MESH:D010636), propionate (MESH:D011422), fructooligosaccharides (MESH:C116580), triglyceride (MESH:D014280), DPPH (MESH:C004931), nitrogen (MESH:D009584), thiamine (MESH:D013831), butyrate (MESH:D002087), Polysaccharides (MESH:D011134)
- **Species:** Oryza sativa (Asian cultivated rice, species) [taxon 4530], Pseudocydonia sinensis (Chinese quince, species) [taxon 36622], Monascus purpureus (species) [taxon 5098], Dendrobium chrysotoxum (species) [taxon 161865], gut metagenome (species) [taxon 749906], Cordyceps cicadae (species) [taxon 218633], Gallus gallus (bantam, species) [taxon 9031], Escherichia coli (E. coli, species) [taxon 562], Coptis chinensis (species) [taxon 261450], Rheum palmatum (species) [taxon 137221], Astragalus membranaceus (species) [taxon 649199], Homo sapiens (human, species) [taxon 9606], Lactobacillus (genus) [taxon 1578], Bifidobacterium (genus) [taxon 1678], Scutellaria baicalensis (Baikal skullcap, species) [taxon 65409], Dendrobium huoshanense (species) [taxon 154293], Bacteria Latreille et al. 1825 (Bacteria stick insect, genus) [taxon 629395], Dendrobium nobile (species) [taxon 94219], Mus musculus (house mouse, species) [taxon 10090], Dendrobium officinale (species) [taxon 142615], Bacteroides fragilis (species) [taxon 817], Rattus norvegicus (brown rat, species) [taxon 10116]

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12932501/full.md

## Figures

3 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12932501/full.md

## References

102 references — full list in the complete paper: https://tomesphere.com/paper/PMC12932501/full.md

---
Source: https://tomesphere.com/paper/PMC12932501